Servier and Celsius Therapeutics Announce Target Discovery Collaboration in Colorectal Cancer
Press release content from Business Wire. The AP news staff was not involved in its creation. Servier and Celsius Therapeutics Announce Target Discovery Collaboration in Colorectal Cancer December 21, 2020 GMT PARIS & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Dec 21, 2020-- Servier, a global pharmaceutical Group, and Celsius Therapeutics, a company focused on bringing precision medicine to patients with cancer and autoimmunity, today announced a strategic collaboration focused on the identification and validation of novel colorectal cancer (CRC) drug targets. “As colorectal cancer remains a leadin...